ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 37689596

Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.

Sohn B and 8 others. J Neurooncol, 2023. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype. Papers, record 37689596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37689596

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.
PubMed
Journal
J Neurooncol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2026-10-31
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sohn BBeomseokhttps://orcid.org/0000-0002-6765-8056
2Park KKisunghttps://orcid.org/0000-0002-7447-4247
3Ahn SSSung Soohttps://orcid.org/0000-0002-0503-5558
4Park YWYae Wonhttps://orcid.org/0000-0001-8907-5401
5Choi SHSeung Honghttps://orcid.org/0000-0002-0412-2270
6Kang SGSeok-Guhttps://orcid.org/0000-0001-5676-2037
7Kim SHSe Hoonhttps://orcid.org/0000-0001-7516-7372
8Chang JHJong Heehttps://orcid.org/0000-0003-1509-9800
9Lee SKSeung-Koohttps://orcid.org/0000-0001-5646-4072

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlioblastomaMajor topic
Brain NeoplasmsMajor topic
Humans
Male
Middle Aged
Isocitrate Dehydrogenase
Magnetic Resonance Imaging
ErbB Receptors
Retrospective Studies

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
RS-2023-00237618Ministry of EducationPubMed
No. 2020R1A2C1003886National Research Foundation of KoreaPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,698,752Hypoxia and EGF Stimulation Regulate VEGF Expression in Human Glioblastoma Multiforme (GBM) Cells by Differential Regulation of the PI3K/Rho-GTPase and MAPK Pathways.Cells2019https://conductscience.org/library/papers/31698752PubMed
222,492,960Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma.Neuro Oncol2012https://conductscience.org/library/papers/22492960PubMed
334,498,213Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.J Neurooncol2021https://conductscience.org/library/papers/34498213PubMed
411,123,261VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly.Am J Physiol Heart Circ Physiol2001https://conductscience.org/library/papers/11123261PubMed
526,275,367Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.J Neurooncol2015https://conductscience.org/library/papers/26275367PubMed
631,125,418Defining EGFR amplification status for clinical trial inclusion.Neuro Oncol2019https://conductscience.org/library/papers/31125418PubMed
731,748,746Longitudinal molecular trajectories of diffuse glioma in adults.Nature2019https://conductscience.org/library/papers/31748746PubMed
833,594,116Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma.Sci Rep2021https://conductscience.org/library/papers/33594116PubMed
931,828,414Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.Eur Radiol2020https://conductscience.org/library/papers/31828414PubMed
1029,092,951Computational Radiomics System to Decode the Radiographic Phenotype.Cancer Res2017https://conductscience.org/library/papers/29092951PubMed

1 to 10 of 51

See all 51 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42,791,469Artificial Intelligence for the Preoperative Molecular Characterization of Adult-Type Diffuse High-Grade Gliomas: A Systematic Review and Meta-Analysis.J Imaging Inform Med2026https://conductscience.org/library/papers/42791469PubMed
42,737,517Integrating Radiogenomics and CSF-Based Liquid Biopsy Sequencing for Precision Neuro-Oncology.Int J Mol Sci2026https://conductscience.org/library/papers/42737517PubMed
42,050,553Glioblastoma radiomics can delineate systemic immune activity states like blood abundance of T cell populations or transcription factors.J Neuroinflammation2026https://conductscience.org/library/papers/42050553PubMed
41,963,831Nano-radiomics of molecular MRI for early amyloid associated patterns in an Alzheimer's disease mouse model via an automatic pipeline.BMC Med Imaging2026https://conductscience.org/library/papers/41963831PubMed
39,455,814Deep learning-based super-resolution and denoising algorithm improves reliability of dynamic contrast-enhanced MRI in diffuse glioma.Sci Rep2024https://conductscience.org/library/papers/39455814PubMed
38,791,871Novel Imaging Approaches for Glioma Classification in the Era of the World Health Organization 2021 Update: A Scoping Review.Cancers (Basel)2024https://conductscience.org/library/papers/38791871PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
IDH13,417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37689596

GET https://conductscience.org/api/papers/v1/37689596/references?page=2

API referenceFor AI assistants